Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency …
Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency … LACHEN, Switzerland–(BUSINESS WIRE)–New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and secondary antibody deficiencies (SAD) were recently published in the European Journal of Haematology. The publication, sponsored by Octapharma, marks the first pan-European consensus guidance […]
Read More